Upadacitinib for Treatment of Granulomatous Cheilitis.

De Greef, Axel; Peeters, Caroline; Dewit, Olivier; De Montjoye, Laurence; Baeck, Marie

doi:10.1001/jamadermatol.2024.2378

Upadacitinib for Treatment of Granulomatous Cheilitis.

De Greef, Axel

;

Peeters, Caroline

;

Dewit, Olivier

;

De Montjoye, Laurence

;

Baeck, Marie

(2024) JAMA dermatology — Vol. 160, n° 9, p. 1001-1003 (2024)

Files

jamadermatology_de_greef_2024_ld_240012_172202752611519.pdf

Open Access
Adobe PDF
404.58 KB

Download

Details

Authors

De Greef, AxelUCLouvain
Author
Peeters, CarolineUCLouvain
Author
Dewit, OlivierUCLouvain
Author
De Montjoye, LaurenceUCLouvain
Author
Baeck, MarieUCLouvain
Author

Abstract

(en) This case series examines the effectiveness of the Janus kinase inhibitor upadacitinib for the treatment of granulomatous cheilitis.

Affiliations

UCLouvainSSS/IREC/LUNS - Pôle pneumologie, ORL (airways) et dermatologie (skin)
UCLouvainSSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie
UCLouvain(SLuc) Service de dermatologie
UCLouvain(SLuc) Service d'hépato-gastro-entérologie

Citations

APA
Chicago
FWB

De Greef, A., Peeters, C., Dewit, O., De Montjoye, L., & Baeck, M. (2024). Upadacitinib for Treatment of Granulomatous Cheilitis. JAMA dermatology, 160(9), 1001-1003. https://doi.org/10.1001/jamadermatol.2024.2378 (Original work published 2024)